Stay current: Follow Cardiac Interventions Today on Twitter @cardiacinterv



Data on Biotronik’s Orsiro Hybrid DES Presented at EuroPCR

May 31, 2016 -- Biotronik announced results establishing the noninferiority of its Orsiro hybrid drug-eluting stent (DES) compared to the Resolute Integrity DES (Medtroni…

BioVentrix’s Pivotal ALIVE Trial Receives IDE Approval From FDA

May 31, 2016 -- BioVentrix Inc. announced that it has received approval from the US Food and Drug Administration (FDA) for an investigational device exemption (IDE) to initiat…

One-Year Data Support Valtech’s Cardioband Mitral Valve Reconstruction System

May 31, 2016 -- One-year follow-up results of a European study of the Cardioband mitral value reconstruction system (Valtech Cardio, Ltd.) were presented at the EuroPCR 2016 …

LEADERS FREE Substudy Presented for Biosensors’ Biofreedom Drug-Coated Stent in ACS Patients

May 31, 2016 -- Results from the LEADERS FREE substudy of the polymer-free Biofreedom biolimus-A9 (BA9) drug-coated stent (Biosensors International Group, Ltd) in acute c…

OPINION Study Shows Good Clinical Outcomes with Optical Frequency Domain Imaging in PCI

May 31, 2016 -- The use of optimal frequency domain imaging (OFDI) to guide percutaneous coronary intervention (PCI) with second-generation drug-eluting stents (DES) has been …

Pooled Analysis Supports Keystone Heart’s TriGuard Cerebral Protection Device in TAVR Procedures

May 23, 2016 -- Keystone Heart, Ltd. announced the presentation of a pooled analysis of three prospective and comparable clinical studies of patients undergoing transcatheter …

Studies Support St. Jude Medical's FFR and LAA Closure Technology

May 19, 2016 -- St. Jude Medical, Inc. announced results from two cardiovascular clinical trials presented at the EuroPCR 2016 conference held May 17 -- 20 in Paris, France. O…

physician counsel

Open Payments Update: Will More Data + More Errors = More Physician Peril?

An early look at samples from the full 2014 Open Payments records suggests that physicians must be ready to review and dispute their records before they go public.

Open Payments Errors Could Put Physicians in a Bad Light

As the Open Payments website becomes more user-friendly, physicians must ensure their disclosures are accurate, or risk misinterpretation.

Invention and Intellectual Property

Protecting Your Inventions, From Idea to Marketplace

The first step in bringing your medical device to market is to understand who owns the rights to your invention.

Beginning the Patent Process

The second step in bringing your medical device to market is to understand whether you can protect your invention.

Evaluating Freedom to Operate

The third step in bringing your medical device to market is to understand whether you can practice your invention.

Featured Center




2016 Buyer’s Guide


This Buyer’s Guide offers a searchable, comprehensive listing of the FDA-approved interventional devices available in the United States.


Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Cardiac Interventions Today

Cardiac Interventions Today is a publication dedicated to providing comprehensive coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions. Cardiac Interventions Today premiered in March 2007, with its launch issue focusing on the state of coronary drug-eluting stent use. Each edition will cover a variety of topics in a flexible format that includes articles covering various perspectives on current clinical topics, in-depth interviews with expert physicians, overviews of available technologies, industry news, and insights into the issues affecting today's cardiology practices.